Is Starpharma Holdings Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Starpharma Holdings Ltd (SPL.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Starpharma Holdings Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Starpharma Holdings Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Starpharma Holdings Ltd?

Muslim investors may consider investing in Starpharma Holdings Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Starpharma Holdings Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Starpharma Holdings Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Starpharma Holdings Ltd updated?

The Shariah compliance status of Starpharma Holdings Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Starpharma Holdings Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Starpharma Holdings Ltd?

You can check the latest Shariah compliance status of Starpharma Holdings Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SPL.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 20, 2025

Report Source: 2025 Annual Report

Starpharma Holdings Ltd. Stock Analysis SPL.AX

Australia Health Care Micro Cap Report: 2025 Annual

Starpharma Holdings Ltd. engages in the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. The firm's principal activities are focused on the research, development and commercialization of dendrimer technology for pharmaceutical and healthcare applications. The firm's portfolio of dendrimer-based products includes three clinical-stage dendrimer enhanced product (DEP) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over the counter (OTC) products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, the Company has a preclinical pipeline of DEP radiopharmaceuticals in development. The company also manufactures and sells SPL7013 (astodrimer sodium) proprietary products: VivaGel BV, Viraleze nasal spray, and VivaGel condom. The firm has applied its DEP technology to the innovative area of antibody-drug conjugates.

Key Statistics of Starpharma Holdings Ltd (SPL.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.58AUD0.65

Today's Open

AUD0.63

Volume

1.87M

P/E Ratio (TTM)

52 Week Range

AUD0.08AUD0.79

Market Cap

311.49M

Avg. Volume

47.58K

Dividend Yield

Financial Metrics & Statements of Starpharma Holdings Ltd (SPL.AX)

FAQ's for Starpharma Holdings Ltd (SPL.AX)

According to Musaffa’s Shariah screening methodology, Starpharma Holdings Ltd (SPL.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.